Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Geriatric brain tumor management part II: Glioblastoma multiforme.

Cohen-Inbar O.

J Clin Neurosci. 2019 Jun 18. pii: S0967-5868(19)30669-1. doi: 10.1016/j.jocn.2019.05.064. [Epub ahead of print] Review.

PMID:
31227406
2.

Geriatric brain tumor management part I: Meningioma.

Cohen-Inbar O.

J Clin Neurosci. 2019 Jun 14. pii: S0967-5868(19)30668-X. doi: 10.1016/j.jocn.2019.05.063. [Epub ahead of print] Review.

PMID:
31208835
3.

Glioblastoma in the elderly - How do we choose who to treat?

Lorimer CF, Saran F, Chalmers AJ, Brock J.

J Geriatr Oncol. 2016 Nov;7(6):453-456. doi: 10.1016/j.jgo.2016.07.005. Epub 2016 Jul 29.

PMID:
27478132
4.

Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.

Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD.

J Neurosurg. 2015 Apr;122(4):757-65. doi: 10.3171/2014.11.JNS13295. Epub 2015 Jan 16.

PMID:
25594327
5.

Management of Glioblastoma Multiforme in Elderly Patients: A Review of the Literature.

Halani SH, Babu R, Adamson DC.

World Neurosurg. 2017 Sep;105:53-62. doi: 10.1016/j.wneu.2017.04.153. Epub 2017 Apr 30. Review.

PMID:
28465276
6.

Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis.

Zarnett OJ, Sahgal A, Gosio J, Perry J, Berger MS, Chang S, Das S.

JAMA Neurol. 2015 May;72(5):589-96. doi: 10.1001/jamaneurol.2014.3739. Review.

PMID:
25822375
7.

A review of management strategies of malignant gliomas in the elderly population.

Kumthekar PU, Macrie BD, Singh SK, Kaur G, Chandler JP, Sejpal SV.

Am J Cancer Res. 2014 Sep 6;4(5):436-44. eCollection 2014. Review.

8.
9.

Antiangiogenic therapy for high-grade glioma.

Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N.

Cochrane Database Syst Rev. 2014 Sep 22;(9):CD008218. doi: 10.1002/14651858.CD008218.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Nov 22;11:CD008218.

PMID:
25242542
10.

A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.

Konar SK, Bir SC, Maiti TK, Nanda A.

J Neurosurg Pediatr. 2017 Feb;19(2):239-248. doi: 10.3171/2016.8.PEDS1631. Epub 2016 Nov 4. Review.

PMID:
27813458
11.

Management of glioblastoma in elderly patients.

Young JS, Chmura SJ, Wainwright DA, Yamini B, Peters KB, Lukas RV.

J Neurol Sci. 2017 Sep 15;380:250-255. doi: 10.1016/j.jns.2017.07.048. Epub 2017 Aug 1. Review.

PMID:
28870580
12.

Treatment options and outcomes for glioblastoma in the elderly patient.

Arvold ND, Reardon DA.

Clin Interv Aging. 2014 Feb 21;9:357-67. doi: 10.2147/CIA.S44259. eCollection 2014. Review.

13.

Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.

Babu R, Komisarow JM, Agarwal VJ, Rahimpour S, Iyer A, Britt D, Karikari IO, Grossi PM, Thomas S, Friedman AH, Adamson C.

J Neurosurg. 2016 Apr;124(4):998-1007. doi: 10.3171/2015.4.JNS142200. Epub 2015 Oct 9.

PMID:
26452121
14.

Topics in chemotherapy, molecular-targeted therapy, and immunotherapy for newly-diagnosed glioblastoma multiforme.

Okonogi N, Shirai K, Oike T, Murata K, Noda SE, Suzuki Y, Nakano T.

Anticancer Res. 2015 Mar;35(3):1229-35. Review.

PMID:
25750269
15.

One decade of glioblastoma multiforme surgery in 342 elderly patients: what have we learned?

Heiland DH, Haaker G, Watzlawick R, Delev D, Masalha W, Franco P, Machein M, Staszewski O, Oelhke O, Nicolay NH, Schnell O.

J Neurooncol. 2018 Nov;140(2):385-391. doi: 10.1007/s11060-018-2964-8. Epub 2018 Aug 3. Erratum in: J Neurooncol. 2018 Sep 10;:.

PMID:
30076585
16.

The role of brachytherapy in the treatment of glioblastoma multiforme.

Barbarite E, Sick JT, Berchmans E, Bregy A, Shah AH, Elsayyad N, Komotar RJ.

Neurosurg Rev. 2017 Apr;40(2):195-211. doi: 10.1007/s10143-016-0727-6. Epub 2016 May 16. Review.

PMID:
27180560
17.

The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme.

Ballman KV, Buckner JC, Brown PD, Giannini C, Flynn PJ, LaPlant BR, Jaeckle KA.

Neuro Oncol. 2007 Jan;9(1):29-38. Epub 2006 Nov 15.

18.

Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.

Ciammella P, Galeandro M, D'Abbiero N, Podgornii A, Pisanello A, Botti A, Cagni E, Iori M, Iotti C.

Clin Neurol Neurosurg. 2013 Sep;115(9):1609-14. doi: 10.1016/j.clineuro.2013.02.001. Epub 2013 Feb 26.

PMID:
23453151
19.

The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists.

Burri SH, Gondi V, Brown PD, Mehta MP.

Am J Clin Oncol. 2018 Feb;41(2):191-196. doi: 10.1097/COC.0000000000000395. Review.

20.

Risk of subsequent cancer among pediatric, adult and elderly patients following a primary diagnosis of glioblastoma multiforme: a population-based study of the SEER database.

Li X, Li Y, Cao Y, Li P, Liang B, Sun J, Feng E.

Int J Neurosci. 2017 Nov;127(11):1005-1011. doi: 10.1080/00207454.2017.1288624. Epub 2017 Mar 17.

PMID:
28288541

Supplemental Content

Support Center